Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial.
Magnus Olof WijkmanBrian ClaggettRafael DiazHertzel C GersteinLars KøberEldrin LewisAldo P MaggioniEmil WolskDavid AguilarRhonda Bentley-LewisJohn J McMurrayJeffrey ProbstfieldMatthew RiddleJean-Claude TardifScott D SolomonMarc A PfefferPublished in: Cardiovascular diabetology (2020)
The association between blood pressure and mortality was modified by additional CVD history in patients with type 2 diabetes and a recent coronary event. When blood pressures measured after an acute coronary event are used to assess the risk of death in patients with type 2 diabetes, the cardiovascular history needs to be taken into consideration. Trial registration ClinicalTrials.gov number NCT01147250, first posted June 22, 2010.
Keyphrases
- blood pressure
- coronary artery disease
- coronary artery
- cardiovascular events
- study protocol
- phase iii
- clinical trial
- hypertensive patients
- phase ii
- risk factors
- heart rate
- liver failure
- randomized controlled trial
- heart failure
- type diabetes
- adipose tissue
- intensive care unit
- insulin resistance
- skeletal muscle
- hepatitis b virus
- aortic dissection
- mechanical ventilation